nrxp: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	18,701	8,975
Net increase (decrease) in cash and cash equivalents	5,741	1,467
Cash and cash equivalents at end of period	7,200	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	18,701	8,975
Net increase (decrease) in cash and cash equivalents	5,741	1,467
Cash and cash equivalents at end of period	7,200	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

NRX Pharmaceuticals, Inc. (NRXP)